Huidagene Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Huidagene Therapeutics General Information

Description

Developer of gene therapy drugs designed for the treatments of rare human genetic diseases. The company specializes in the development and production of gene replacement and gene editing therapeutic products based on Adeno-Associated Virus technologies, providing sophisticated and reliable research and solutions for the treatment of various neurodegenerative diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 3, 6th Floor, Building 5
  • Number 160, Basheng Road, Pudong New Area
  • Shanghai, 200131
  • China
+86 021
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Unit 3, 6th Floor, Building 5
  • Number 160, Basheng Road, Pudong New Area
  • Shanghai, 200131
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huidagene Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Mar-2026 Completed Generating Revenue
5. Later Stage VC (Series C) 12-May-2022 Completed Generating Revenue
4. Secondary Transaction - Private 07-Sep-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 17-May-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 02-Dec-2019 $14.2M $18.6M Completed Generating Revenue
1. Seed Round 01-Nov-2018 $4.34M $4.34M Completed Generating Revenue
To view Huidagene Therapeutics’s complete valuation and funding history, request access »

Huidagene Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of gene therapy drugs designed for the treatments of rare human genetic diseases. The company specializes in t
Drug Delivery
Shanghai, China
150 As of 2022

Somerville, MA
 

Beijing, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Huidagene Therapeutics Competitors (29)

One of Huidagene Therapeutics’s 29 competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
EdiGene Venture Capital-Backed Beijing, China
Belief BioMed Venture Capital-Backed Shanghai, China
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
Sangamo Therapeutics Formerly VC-backed Richmond, CA
You’re viewing 5 of 29 competitors. Get the full list »

Huidagene Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Huidagene Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
HM Venture Partners Venture Capital Minority
Beijing Ruiyin Weiye Technology Development Growth/Expansion Minority
Kunnuo Tianqin Venture Capital Corporate Venture Capital Minority
GL Ventures Venture Capital Minority
HM Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Huidagene Therapeutics FAQs

  • When was Huidagene Therapeutics founded?

    Huidagene Therapeutics was founded in 2018.

  • Where is Huidagene Therapeutics headquartered?

    Huidagene Therapeutics is headquartered in Shanghai, China.

  • What is the size of Huidagene Therapeutics?

    Huidagene Therapeutics has 150 total employees.

  • What industry is Huidagene Therapeutics in?

    Huidagene Therapeutics’s primary industry is Drug Delivery.

  • Is Huidagene Therapeutics a private or public company?

    Huidagene Therapeutics is a Private company.

  • What is Huidagene Therapeutics’s current revenue?

    The current revenue for Huidagene Therapeutics is .

  • How much funding has Huidagene Therapeutics raised over time?

    Huidagene Therapeutics has raised $80.4M.

  • Who are Huidagene Therapeutics’s investors?

    HM Venture Partners, Beijing Ruiyin Weiye Technology Development, Kunnuo Tianqin Venture Capital, GL Ventures, and HM Capital are 5 of 7 investors who have invested in Huidagene Therapeutics.

  • Who are Huidagene Therapeutics’s competitors?

    Genetix Biotherapeutics, EdiGene, Belief BioMed, CRISPR Therapeutics, and Sangamo Therapeutics are some of the 29 competitors of Huidagene Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process